Hypomethylating agents (HMA) treatment for myelodysplastic syndromes: alternatives in the frontline and relapse settings

Natalie Uy, Abhay Singh, Steven D. Gore, Thomas Prebet

Research output: Contribution to journalReview article

Fingerprint Dive into the research topics of 'Hypomethylating agents (HMA) treatment for myelodysplastic syndromes: alternatives in the frontline and relapse settings'. Together they form a unique fingerprint.

Medicine & Life Sciences